Skip to main content
. Author manuscript; available in PMC: 2021 Apr 9.
Published in final edited form as: Lancet Gastroenterol Hepatol. 2020 Aug 17;5(11):986–995. doi: 10.1016/S2468-1253(20)30267-3

Table 1:

Patient characteristics at the time of inflammatory bowel disease diagnosis and their matched general population controls, 2007–2016

Cases
n=23,982#
Controls
n=117,827
Ulcerative colitis
n=15,951
Crohn’s disease
n=7,898
Age, years 36 [24–56] 31 [19–51] 35 [22–54]
 <18 1,755 (11) 1,686 (21) 17,699 (15)
 18–24 2,552 (16) 1,422 (18) 20,421 (17)
 25–34 3,190 (20) 1,343 (17) 22,785 (19)
 35–44 2,233 (14) 948 (12) 15,843 (13)
 45–54 1,914 (12) 790 (10) 13,451 (12)
 55–64 2,072 (13) 869 (11) 13,487 (12)
 ≥65 2,235 (14) 840 (11) 14,141 (12)
Male sex, n (%) 8,543 (54) 3,997 (51) 62,010 (52)
Region of residence, n (%)
 Northern Sweden 1,417 (9) 590 (7) 9,926 (8)
 Southeastern Sweden 1,816 (11) 923 (12) 13,572 (12)
 Southern Sweden 3,030 (19) 1,518 (19) 22,390 (19)
 Stockholm-Gotland 3,071 (19) 2,047 (26) 25,229 (21)
 Uppsala-Örebro 3,489 (22) 1,592 (20) 25,216 (21)
 Western Sweden 3,026 (19) 1,178 (15) 20,922 (18)
 Unknown 102 (1) 50 (1) 572 (1)
Education, n (%)
 ≤9 years 2,829 (18) 1,540 (20) 21,030 (18)
 10–12 years 7,121 (45) 3,473 (44) 50,542 (43)
 ≥13 years 5,563 (35) 2,430 (31) 41,092 (35)
 Unknown 438 (3) 455 (6) 5,163 (4)
Number of encounters*, n
 Inpatient 2 [0–4] 2 [0–4] 1 [0–3]
 Outpatient 5 [2–11] 6 [2–13] 3 [1–9]
Calendar year
 2007–2009 4,786 (30) 2,186 (28) 34,449 (29)
 2010–2013 7,031 (44) 3,570 (45) 52,373 (44)
 2014–2016 4,134 (26) 2,142 (27) 31,005 (26)

Values are median [IQR] or absolute figures (percentages). Polytomous variables may not sum to 100% due to rounding.

#

includes ulcerative colitis, Crohn’s disease, and IBD-unclassified

*

calculated the number of inpatient and outpatient encounters (continuous) for each participant during the study period up until the time of matching/case diagnosis.